Drug profile · INN
fluvastatin sodium
FLUVASTATIN SODIUM
fluvastatin sodium (FLUVASTATIN SODIUM) is a hmg-coa reductase inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — fluvastatin sodium
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 3
- Programs
- 0
- Data quality
- 0.89
Quick answer
fluvastatin sodium (FLUVASTATIN SODIUM) is a hmg-coa reductase inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
HMG-CoA reductase inhibitor
Primary target: 3-hydroxy-3-methylglutaryl-coenzyme A reductase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Related patents
-
US 7687642
Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them
granted -
US 7414140
Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them
granted -
US 7368468
Fluvastatin sodium crystal forms XIV, LXXIII, LXXIX, LXXX and LXXXVII, processes for preparing them, compositions containing them and methods of using them
granted
Frequently asked questions
What is fluvastatin sodium?
fluvastatin sodium (FLUVASTATIN SODIUM) is a hmg-coa reductase inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for fluvastatin sodium?
FLUVASTATIN SODIUM is a marketed brand name for fluvastatin sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of fluvastatin sodium?
fluvastatin sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.